Cargando…
Potential biomarkers and challenges in glioma diagnosis, therapy and prognosis
Gliomas are the most common central nervous system malignancies and present with significant morbidity and mortality. Treatment modalities are currently limited to surgical resection, chemotherapy and radiotherapy. Increases in survival rate over the previous decades are negligible, further pinpoint...
Autores principales: | Kan, Liyen Katrina, Drummond, Kate, Hunn, Martin, Williams, David, O'Brien, Terence J, Monif, Mastura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871709/ https://www.ncbi.nlm.nih.gov/pubmed/33681797 http://dx.doi.org/10.1136/bmjno-2020-000069 |
Ejemplares similares
-
A Simple and Reliable Protocol for the Preparation and Culturing of Fresh Surgically Resected Human Glioblastoma Tissue
por: Kan, Liyen Katrina, et al.
Publicado: (2020) -
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastoma
por: Kan, Liyen K., et al.
Publicado: (2023) -
Inhibition of purinergic P2X receptor 7 (P2X7R) decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) expression in U251 glioblastoma cells
por: Drill, Matthew, et al.
Publicado: (2020) -
Prognosis in autoimmune encephalitis: Database
por: Broadley, James, et al.
Publicado: (2018) -
The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
por: O’Brien, William T., et al.
Publicado: (2020)